Study for the Prevention of Ascites (SPA): comparison of fixed doses of SR121463B [satavaptan] versus placebo in the reduction of recurrence of cirrhotic ascites
Latest Information Update: 13 Aug 2007
At a glance
- Drugs Satavaptan (Primary) ; Spironolactone
- Indications Ascites
- Focus Therapeutic Use
- Acronyms SPA
- Sponsors Sanofi
- 13 Aug 2007 New trial record.